Population

Diadem Announces New Publication Reviewing How Post Translational Modifications of p53 Variants May Contribute to Development of Alzheimer's Disease

Thursday, September 23, 2021 - 7:00am

Increasing evidence suggests that certain conformational variants and post-translational modifications of p53, well known for its role in cancer, may significantly impact the development of AD.

Key Points: 
  • Increasing evidence suggests that certain conformational variants and post-translational modifications of p53, well known for its role in cancer, may significantly impact the development of AD.
  • This knowledge is already fueling creation of novel prognostic tests for AD and may lead to the development of new therapies to counter disease progression."
  • p53 is involved in the regulation of oxidative stress, which is implicated as one of the earliest events in AD.
  • Diadem is preparing for rapid commercialization of its initial Alzheimer's prognostic via a global launch in collaboration with strategic partners.

Sodexo Live! and Harris Interactive announce audiences are ready to go live again!

Thursday, September 23, 2021 - 7:00am

presents the 3rd wave of its survey on how audiences feel about coming back to live events in the age of COVID-19, launched with the Harris Interactive Institute in June 2020 and followed up in October of the same year.

Key Points: 
  • presents the 3rd wave of its survey on how audiences feel about coming back to live events in the age of COVID-19, launched with the Harris Interactive Institute in June 2020 and followed up in October of the same year.
  • This comes as an extremely positive sign of the live experience coming back to life with audiences that are eager to participate.
  • Let's take a closer look at the main lessons from the Sodexo Live!
  • Consumers in all markets are now more willing to visit cultural venues or attend events, whether sporting, cultural or professional.

Home Affordability Slips Again For Average Workers Across U.S. In Third Quarter Amid Ongoing Price Runup

Thursday, September 23, 2021 - 5:01am

That required income was then compared to annualized average weekly wage data from the Bureau of Labor Statistics (see full methodology below).

Key Points: 
  • That required income was then compared to annualized average weekly wage data from the Bureau of Labor Statistics (see full methodology below).
  • That is up from 24.3 percent in the second quarter of 2021 and 22.3 percent in the third quarter of last year.
  • "The typical median-priced home around the U.S. remains affordable to workers earning an average wage, despite prices that keep going through the roof.
  • That's pushing average workers closer and closer to the point where lenders might be reluctant to give them a mortgage.

Amplitude Healthcare Acquisition Corporation Announces Shareholder Approval of Business Combination with Jasper Therapeutics, Inc.

Wednesday, September 22, 2021 - 11:38pm

REDWOOD CITY, Calif. and NEW YORK, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Amplitude Healthcare Acquisition Corporation (Nasdaq: AMHC) (“AMHC”), a special purpose acquisition company, today announced that its stockholders voted to approve the previously announced business combination (the “Business Combination”) with Jasper Therapeutics, Inc. (“Jasper”), a biotechnology company focused on the development of novel curative therapies based on the biology of the hematopoietic stem cell, and all other proposals presented at AMHC’’s special shareholder’s meeting held on September 22, 2021.

Key Points: 
  • AMHCs shareholders approved the Business Combination proposal with 74.9% votes in favor of the approximately 9,872,643 AMHC votes cast at the meeting.
  • Holders of 9,262,099 shares of AMHC Class A common stock have elected to redeem their shares in connection with the Business Combination.
  • Subject to the satisfaction or waiver of the other customary closing conditions, the Business Combination is expected to close on or about September 24, 2021.
  • AMHC and Jasper Therapeutics anticipate that subsequent events and developments will cause AMHCs and Jasper Therapeutics assessments to change.

Innovaccer Featured in LinkedIn's 2021 Top U.S. Startups List

Wednesday, September 22, 2021 - 11:05pm

SAN FRANCISCO, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Today, Innovaccer Inc., the Health Cloud company, announced that it is profiled on LinkedIn's 5th annual " Top Startups 2021 " list, published today.

Key Points: 
  • SAN FRANCISCO, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Today, Innovaccer Inc., the Health Cloud company, announced that it is profiled on LinkedIn's 5th annual " Top Startups 2021 " list, published today.
  • The list reveals 50 young, emerging companies chosen for their high employee growth, jobseeker interest,member engagement with the company and its employees, and how well the startups attracted talent from LinkedIn's Top Companies list .
  • The Top Startups list features new companies that offer fast-paced growth opportunities to their employees along with new skill development and financial incentives.
  • To develop the Top Startups list, LinkedIn leverages the data of its 774M users to assess each new company's employee engagement rate, growth, and attraction of top talent.

AvaDent hires Devon Howe as General Manager

Wednesday, September 22, 2021 - 11:08pm

SCOTTSDALE, Ariz., Sept. 22, 2021 /PRNewswire/ -- AvaDent, the leader in digital removable dental solutions, today announced the hiring of Devon Howe as General Manager of the U.S. operations.

Key Points: 
  • SCOTTSDALE, Ariz., Sept. 22, 2021 /PRNewswire/ -- AvaDent, the leader in digital removable dental solutions, today announced the hiring of Devon Howe as General Manager of the U.S. operations.
  • Devon brings nearly 40 years of experience expanding portfolio offerings and global market reach through product innovation, IP development, M&A, regulatory and licensing.
  • "Devon comes to us from National Dentex where he was General Manager of the NDX Sarasota, Florida facility, one of the largest facilities in the NDX network.
  • We are looking forward to Devon's taking AvaDent and our customer experience to the next level in the Digital Denture market," said Tim Thompson, CEO of AvaDent.

Global Water Resources to Acquire Las Quintas Serenas Water Company in Pima County, Arizona

Wednesday, September 22, 2021 - 9:45pm

PHOENIX, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), (TSX: GWR), a pure-play water resource management company, has signed a definitive agreement to acquire Las Quintas Serenas Water Company located near Tucson in Pima County, Arizona.

Key Points: 
  • PHOENIX, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), (TSX: GWR), a pure-play water resource management company, has signed a definitive agreement to acquire Las Quintas Serenas Water Company located near Tucson in Pima County, Arizona.
  • The size and close proximity of Las Quintas Serenas to our other utilities helps make it an ideal addition to our portfolio, stated Global Water Resources president and CEO, Ron Fleming.
  • As part of its initiatives for Las Quintas Serenas, Global Water plans to upgrade the utilitys connections from manually read meters to smart meters.
  • Global Water Resources, Inc. is a leading water resource management company that owns and operates 16 utilities which provide water, wastewater, and recycled water services.

Arcturus Therapeutics Announces Meeting with President of Vietnam and CEO of Vingroup to Discuss Expansion of COVID-19 Vaccine Collaboration

Wednesday, September 22, 2021 - 9:01pm

It was an honor to meet with President Nguyen Xuan Phuc and the delegation to discuss Vietnams progressive public health strategy.

Key Points: 
  • It was an honor to meet with President Nguyen Xuan Phuc and the delegation to discuss Vietnams progressive public health strategy.
  • Vietnam should be acknowledged for its thoughtful planning and aggressive actions to combat this pandemic, including its proactive approach to secure early access to vaccines targeting SARS-CoV-2 variants of concern.
  • Arcturus versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, replicon RNA, antisense RNA, microRNA, DNA, and gene editing therapeutics.
  • Arcturus technologies are covered by its extensive patent portfolio (231 patents and patent applications, issued in the U.S., Europe, Japan, China and other countries).

HealthCheck360 Partners With meQuilibrium to Provide Digital Workforce Resilience Solutions

Wednesday, September 22, 2021 - 8:00pm

DUBUQUE, Iowa, Sept. 22, 2021 (GLOBE NEWSWIRE) -- HealthCheck360, a leader in population health management and wellbeing programs for employers, is expanding its suite of services by offering meQuilibrium 's digital workforce resilience platform.

Key Points: 
  • DUBUQUE, Iowa, Sept. 22, 2021 (GLOBE NEWSWIRE) -- HealthCheck360, a leader in population health management and wellbeing programs for employers, is expanding its suite of services by offering meQuilibrium 's digital workforce resilience platform.
  • "Our partnership with HealthCheck360 reinforces their commitment to equipping employees to lead healthy, productive, happy lives," says Jan Bruce, CEO and co-founder, meQuilibrium.
  • meQuilibrium's award-winning digital solutions build resilience at the individual, manager and organizational levels across the world for more than 40 Fortune 500 companies.
  • meQuilibrium harnesses the science of resilience, AI, predictive analytics, biometrics and neuroscience to help businesses build workforce wellbeing and potential.

Medistar Corporation and Voyages Behavioral Health Announce Development of a Behavioral Health Hospital in Pensacola

Wednesday, September 22, 2021 - 6:00pm

PENSACOLA, Fla., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Medistar Corporation ("Medistar") and Voyages Behavioral Health ("Voyages"; an affiliate of PAM Health) are pleased to announce the development of Voyages Behavioral Health of Pensacola, a state-of-the-art behavioral health hospital.

Key Points: 
  • PENSACOLA, Fla., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Medistar Corporation ("Medistar") and Voyages Behavioral Health ("Voyages"; an affiliate of PAM Health) are pleased to announce the development of Voyages Behavioral Health of Pensacola, a state-of-the-art behavioral health hospital.
  • When completed in 2022, Voyages Behavioral Health of Pensacola will be one of the first hospitals to integrate inpatient medical and psychiatric care.
  • Identifiying a need in behavioral health services across the country, PAM Health established Voyages Behavioral Health to offer an additional service line and specialized care to this underserved patient population.
  • Voyages Behavioral Health chose Pensacola to provide much-needed services in the growing Pensacola MSA (Pensacola-Ferry Pass-Brent, FL metropolitan statistical area), which has a population of over 500,000.